Drugs Technical Committee

تاريخ	جدول الأعمال	مقررات اللجنة
12-11-2015	Agenda12.11.2015
11-11-2015	Agenda11.11.2015
22-10-2015	Agenda22.10.2015	Decisions22.10.2015
21-10-2015	Agenda21.10.2015	Decisions21.10.2015
20-10-2015	Agenda20.10.2015	Decisions20.10.2015
19-10-2015	Agenda19.10.2015	Decisions19.10.2015
8-10-2015	Agenda8.10.2015	Decisions8.10.2015
7-10-2015	Agenda7.10.2015	Decisions7.10.2015
30-9-2015	Agenda30.9.2015	Decisions30.9.2015
29-9-2015	Agenda29.9.2015	Decisions29.9.2015
16-9-2015	Agenda16.9.2015	Decisions16.9.2015
15-9-2015	Agenda15.9.2015	Decisions15.9.2015
2-9-2015	Agenda2.9.2015	Decisions2.9.2015
1-9-2015	Agenda1.9.2015	Decisions1.9.2015
20-8-2015	Agenda20.8.2015	Decisions20.8.2015
19-8-2015	Agenda19.8.2015	Decisions19.8.2015
13-8-2015	Agenda13.8.2015	Decisions13.8.2015
12-8-2015	Agenda12.8.2015	Decisions12.8.2015
6-8-2015	Agenda6.8.2015	Decisions6.8.2015
5-8-2015	Agenda5.8.2015	Decisions5.8.2015
29-7-2015	Agenda29.7.2015	Decisions29.7.2015
28-7-2015	Agenda28.7.2015	Decisions28.7.2015
15-7-2015	Agenda15.7.2015	Decisions15.7.2015
14-7-2015	Agenda14.7.2015	Decisions14.7.2015
8-7-2015	Agenda8.7.2015	Decisions8.7.2015
7-7-2015	Agenda7.7.2015	Decisions7.7.2015
25-6-2015	Agenda25.6.2015	Decisions25.6.2015
24-6-2015	Agenda24.6.2015	Decisions24.6.2015
5-6-2015	Agenda5.6.2015	Decisions5.6.2015
4-6-2015	Agenda4.6.2015	Decisions4.6.2015
2-6-2015	Agenda2.6.2015	Decisions2.6.2015
1-6-2015	Agenda1.6.2015	Decisions1.6.2015
28-5-2015	Agenda28.5.2015	Decisions28.5.2015
27-5-2015	Agenda27.5.2015	Decisions27.5.2015
14-5-2015	Agenda14.5.2015	Decisions14.5.2015
13-5-2015	Agenda13.5.2015	Decisions13.5.2015
5-5-2015	Agenda5.5.2015	Decisions5.5.2015
4-5-2015	Agenda4.5.2015	Decisions4.5.2015
23-4-2015	Agenda23.4.2015	Decisions23.4.2015
22-4-2015	Agenda22.4.2015	Decisions22.4.2015
21-4-2015	Agenda21.4.2015	Decisions21.4.2015
20-4-2015	Agenda20.4.2015	Decisions20.4.2015
16-4-2015	Agenda16.4.2015	Decisions16.4.2015
15-4-2015	Agenda15.4.2015	Decisions15.4.2015
19-3-2015	Agenda19.3.2015	Decisions19.3.2015
18-3-2015	Agenda18.3.2015	Decisions18.3.2015
12-3-2015	Agenda12.3.2015	Decisions12.3.2015
11-3-2015	Agenda11.3.2015	Decisions11.3.2015
6-3-2015	Agenda6.3.2015	Decisions6.3.2015
5-3-2015	Agenda5.3.2015	Decisions5.3.2015
20-2-2015	Agenda20.2.2015	Decisions20.2.2015
19-2-2015	Agenda19.2.2015	Decisions19.2.2015
18-2-2015	Agenda18.2.2015	Decisions18.2.2015
17-2-2015	Agenda17.2.2015	Decisions17.2.2015
12-2-2015	Agenda12.2.2015	Decisions12.2.2015
11-2-2015	Agenda11.2.2015	Decisions11.2.2015
17-1-2015	Agenda17.1.2015	Decisions17.1.2015
16-1-2015	Agenda16.1.2015	Decisions16.1.2015
13-1-2015	Agenda13.1.2015	Decisions13.1.2015
12-1-2015	Agenda12.1.2015	Decisions12.1.2015
7-1-2015	Agenda7.1.2015	Decisions7.1.2015
5-1-2015	Agenda5.1.2015	Decisions5.1.2015
30-12-2014	Agenda30.12.2014	Decisions30.12.2014
29-12-2014	Agenda29.12.2014	Decisions29.12.2014
18-12-2014	Agenda18.12.2014	Decisions18.12.2014
17-12-2014	Agenda17.12.2014	Decisions17.12.2014
3-12-2014	Agenda3.12.2014	Decisions3.12.2014
2-12-2014	Agenda2.12.2014	Decisions2.12.2014
20-11-2014	Agenda20.11.2014	Decisions20.11.2014
19-11-2014	Agenda19.11.2014	Decisions19.11.2014
13-11-2014	Agenda13.11.2014	Decisions13.11.2014
12-11-2014	Agenda12.11.2014	Decisions12.11.2014
5-11-2014	Agenda5.11.2014	Decisions6.11.2014
4-11-2014	Agenda4.11.2014	Decisions5.11.2014
14-10-2014	Agenda14.10.2014	Decisions14.10.2014
13-10-20104	Agenda13.10.2014	Decisions13.10.2014
11-10-2014	Agenda11.10.2014	Decisions11.10.2014
10-10-2014	Agenda10.10.2014	Decisions10.10.2014
3-10-2014	Agenda3.10.2014	Decisions3.10.2014
2-10-2014	Agenda2.10.2014	Decisions2.10.2014
30-9-2014	Agenda30.9.2014	Decisions30.9.2014
29-9-2014	Agenda29.9.2014	Decisions29.9.2014
18-9-2014	Agenda18.9.2014	Decisions18.9.2014
17-9-2014	Agenda17.9.2014	Decisions17.9.2014
5-9-2014	Agenda5.9.2014	Decisions5.9.2014
4-9-2014	Agenda4.9.2014	Decisions4.9.2014
27-8-2014	Agenda27.8.2014	Decisions27.8.2014
26-8-2014	Agenda26.8.2014	Decisions26.8.2014
20-8-2014	Agenda20.8.2014	Decisions20.8.2014
19-8-2014	Agenda19.8.2014	Decisions19.8.2014
13-8-2014	Agenda13.8.2014	Decisions13.8.2014
12-8-2014	Agenda12.8.2014	Decisions12.8.2014
24-7-2014	Agenda24.7.2014	Decisions24.7.2014
23-7-2014	Agenda23.7.2014	Decisions23.7.2014
16-7-2014	Agenda16.7.2014	Decisions16.7.2014
15-7-2014	Agenda15.7.2014	Decisions15.7.2014
10-7-2014	Agenda10.7.2014	Decisions10.7.2014
9-7-2014	Agenda9.7.2014	Decisions9.7.2014
25-6-2014	Agenda25.6.2014	Decisions25.6.2014
23-6-2014	Agenda23.6.2014	Decisions23.6.2014
16-6-2014	Agenda16.6.2014	Decisions16.6.2014
9-6-2014	Agenda9.6.2014	Decisions9.6.2014
31-5-2014	Agenda31.5.2014	Decisions31.5.2014
30-5-2014	Agenda30.5.2014	Decisions30.5.2014
21-5-2014	Agenda21.5.2014	Decisions21.5.2014
20-5-2014	Agenda20.5.2014	Decisions20.5.2014
14-5-2014	Agenda14.5.2014	Decisions14.5.2014
13-5-2014	Agenda13.5.2014	Decisions13.5.2014
25-4-2014	Agenda25.4.2014	Decisions25.4.2014
24-4-2014	Agenda24.4.2014	Decisions24.4.2014
23-4-2014	Agenda23.4.2014	Decisions23.4.2014
22-4-2014	Agenda22.4.2014	Decisions22.4.2014
8-4-2014	Agenda8.4.2014	Decisions8.4.2014
7-4-2014	Agenda7.4.2014	Decisions7.4.2014
11-3-2014	Agenda11.3.2014	Decisions11.3.2014
10-3-2014	Agenda10.3.2014	Decisions10.3.2014
8-3-2014	Agenda8.3.2014	Decisions8.3.2014
7-3-2014	Agenda7.3.2014	Decisions7.3.2014
6-3-2014	Agenda6.3.2014	Decisions6.3.2014
5-3-2014	Agenda5.3.2014	Decisions5.3.2014
26-2-2014	Agenda26.2.2014	Decisions26.2.2014
25-2-2014	Agenda25.2.2014	Decisions25.2.2014
12-2-2014	Agenda12.2.2014	Decisions12.2.2014
11-2-2014	Agenda11.2.2014	Decisions11.2.2014
18-1-2014	Agenda18.1.2014	Decisions18.1.2014
17-1-2014	Agenda17.1.2014	Decisions17.1.2014
16-1-2014	Agenda16.1.2014	Decisions16.1.2014
15-1-2014	Agenda15.1.2014	Decisions15.1.2014
3-1-2014	Agenda3.1.2014	Decisions3.1.2014
2-1-2014	Agenda2.1.2014	Decisions2.1.2014

ATC	brand_name	B/G	Ingredients	Dosage	Form	Price
J07BB01	VAXIGRIPTETRA, VACCIN GRIPPAL QUADRIVALENT (INACTIVE A VIRION FRAGMENTE)	B	Influenza vaccine virus (inactivated, split) - 15mcg/4strains/0.5ml		Injectable suspension	970,254 L.L
J07BB01	GC FLU QUADRIVALENT INFLUENZA VACCINE	G	Influenza vaccine inactivated (split virion, purified, quadrivalent) (H1N1, H3N2,BVR-26, B/Phuket/3073/2013) - 15mcg/4strains/0.5ml		Injectable suspension	791,523 L.L
J07BB02	INFLUVAC	B	Grippal virus surface antigen 3strains - 15mcgx3strains/0.5ml		Injectable suspension	573,821 L.L
J07BC01	ENGERIX-B 20	B	Hepatitis B, purified antigen - 20mcg/ml	20mcg/ml	Injectable suspension	1,652,926 L.L
J07BC01	ENGERIX-B 10	B	Hepatitis B, surface antigen - 10mcg/0.5ml	10mcg/0.5ml	Injectable suspension	1,042,822 L.L
J07BC01	HEPATITIS-B VACCINE (r DNA) PAEDIATRIC	G	Hepatitis B, purified surface antigen adsorbed on aluminium hydroxide (Al+++) (0.25mg to 0.40mg) - 10mcg/0.5ml	10mcg/0.5ml	Injectable suspension	646,388 L.L
J07BC02	HAVRIX '1440'	B	Hepatitis A, inactivated, whole virus - 1,440 ELISA units/ml	1,440 ELISA units/ml	Injectable suspension	2,215,996 L.L
J07BC02	HAVRIX JUNIOR 720	B	Hepatitis A, inactivated, whole virus - 720 ELISA units/0.5ml	720 ELISA units/0.5ml	Injectable suspension	1,491,665 L.L
J07BC02	AVAXIM PEDIATRIQUE (vaccin inactiv de l'h patite A adsorb )	B	Hepatitis A, inactivated, whole virus - 80 antigen units/0.5ml	80 antigen units/0.5ml	Injectable suspension	1,531,980 L.L
J07BC02	VAQTA	B	Hepatitis A, inactivated, whole virus - 25U/0.5ml	25U/0.5ml	Injectable suspension	2,539,862 L.L
J07BC02	HEALIVE-HEPATITIS A VACCINE (HUMAN DIPLOID CELL) INACTIVATED	BioTech	Hepatitis A, inactivated antigen (TZ84 Strain), human diploid cell - 0.5ml/dose	0.5ml/dose	Injectable suspension	1,777,904 L.L
J07BC02	HEALIVE-HEPATITIS A VACCINE (HUMAN DIPLOID CELL) INACTIVATED	BioTech	Hepatitis A, inactivated antigen (TZ84 Strain), human diploid cell - 1ml/dose	0.5ml/dose	Injectable suspension	2,257,655 L.L
J07BF03	POLIOMYELITIS VACCINE INACTIVATED	B	Poliomyelitis virus type 1 inactivated - 40D.U, Poliomyelitis virus type 2 inactivated - 8D.U, Poliomyelitis virus type 3 inactivated - 32D.U		Injectable suspension	1,206,771 L.L
L03AB03	IMUKIN	BioTech	Interferon gamma - 100mcg/0.5ml	100mcg/0.5ml	Injectable suspension	6,348,312 L.L
J07BK01	VARICELLA VACCINE LIVE	BioTech	Varicella-herpes zoster virus (Oka strain), grown in human diploid cells (SV-cell line), live attenuated -		Injectable suspension	3,104,276 L.L
J07BM03	GARDASIL 9 HUMAN PAPILLOMAVIRUS 9- VALENT VACCINE RECOMBINANT	B	Papillomavirus (human type 6) - 30mcg/0.5ml, Papillomavirus (human type 11) - 40mcg/0.5ml, Papillomavirus (human type 16) - 60mcg/0.5ml, Papillomavirus (human type 18) - 40mcg/0.5ml, Papillomavirus (human type 31) - 20mcg/0.5ml, Papillomavirus (human type 33) - 20mcg/0.5ml, Papillomavirus (human type 45) - 20mcg/0.5ml, Papillomavirus (human type 52) - 20mcg/0.5ml, Papillomavirus (human type 58) - 20mcg/0.5ml		Injectable suspension	14,139,396 L.L
J07CA02	TETRAXIM (Vaccin Diphterique, tetanique, coquelucheux acellulaire et Poliomyelitique inactiv adsorb )	B	Diphteria toxoid purified - ?30IU, Tetanus toxoid purified - ?40IU, Poliomyelitis virus type 1 inactivated - 40D.U., Poliomyelitis virus type 2 inactivated - 8D.U., Poliomyelitis virus type 3 inactivated - 32D.U., Bordetella Pertussis Antigens: toxoid - 25mcg, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg		Injectable suspension	1,628,737 L.L
J07CA09	INFANRIX HEXA	B	Diphteria toxoid purified (Prefilled syringe) - ?30IU/0.5ml, Tetanus toxoid purified (prefilled syringe) - ?40IU/0.5ml, Bordetella pertussis antigen (Prefilled syringe) - toxoid 25mcg+filamentous haemaglutinin 25mcg+pertactin 8mcg/0.5ml, Poliomyelitis virus type 1 antigen (prefilled syringe) - 40D.U./0.5ml, Poliomyelitis virus type 2 antigen(prefilled syringe) - 8D.U./0.5ml, Poliomyelitis virus type 3 antigen (prefilled syringe) - 32D.U./0.5ml, HBs Antigen (prefilled syringe) - 10mcg/0.5ml, H. Influenza type b polysaccharide (Vial) - 10mcg/0.5ml		Injectable suspension	4,230,416 L.L
J07CA09	HEXAXIM	BioTech	Diphteria Toxoid - ?20IU/0.5ml, Tetanus toxoid - ?40IU/0.5ml, Bordetella Pertussis Antigens: toxoid - 25mcg/0.5ml, Bordetella Pertussis Antigens: filamentous haemagglutinin - 25mcg/0.5ml, Polio virus inactivated type 1 (Mahoney strain) - 40D antigen units/0.5ml, Polio virus inactivated type 2 (MEF-I strain) - 8D antigen units/0.5ml, Polio virus inactivated type 3 (Saukett strain) - 32D antigen units/0.5ml, Hepatitis B, surface antigen - 10mcg/0.5ml, H. Influenza type b polysaccharide1 ,2 - 12mcg/0.5ml, 1 conjugated to tetanus protein - 22-36mcg, 2 adsorbed on aluminium hydroxide hydrated, Al+++ - 0.6mg		Injectable suspension	4,462,901 L.L
J07CA09	HEXASIIL VACCINE (DIPHTERIA, TETANUS, PERTUSSIS, HEPATITIS B, POLIO, HAEMOPHILUS INFLUENZA TYPE B)		Diphteria Toxoid - ?30IU/0.5ml, Tetanus toxoid - ?40IU/0.5ml, Bordetella pertussis (Whole cell) - ?4IU/0.5ml, Hepatitis B, surface antigen - 15mcg/0.5ml, Polio virus inactivated type 1 (Mahoney strain) - 40D antigen units/0.5ml, Polio virus inactivated type 2 (MEF-I strain) - 8D antigen units/0.5ml, Polio virus inactivated type 3 (Saukett strain) - 32D antigen units/0.5ml, H. Influenza type b polysaccharide1 ,2 - 10mcg/0.5ml, 1 conjugated to tetanus protein - 19-33mcg, 2 adsorbed on aluminium hydroxide hydrated, Al+++ - ?1.25mg		Injectable suspension	3,594,779 L.L
J07CA11	DIPHTHERIA, TETANUS,PERTUSSIS, HEPATITIS B AND HAEMOPHILUS INFLUENZAE TYPE B CONJUGATE VACCINE	B	Diphteria Toxoid1 - ?25Lf (?30IU)/0.5ml, Tetanus toxoid1 - ?2.5Lf (?40IU)/0.5ml, Bordetella pertussis (Whole cell) - ?16OU (?4.0IU)/0.5ml, HBs Antigen (r DNA)1 - ?10mcg/0.5ml, H. Influenza type b, purified capsular polysaccharide2 - 10mcg/0.5ml, 1 adsorbed on aluminium phosphate, Al+++ - ?1.25mg , 2 conjugated to tetanos toxoid carrier protein -		Injectable suspension	1,515,854 L.L
H02AB01	DIPROFOS	B	Betamethasone (dipropionate) - 5mg/ml, Betamethasone (sodium phosphate) - 2mg/ml		Injectable suspension	446,156 L.L
H02AB04	DEPO MEDROL	B	Methylprednisolone acetate - 40mg/ml	40mg/ml	Injectable suspension	182,763 L.L
H02AB04	DEPO MEDROL	B	Methylprednisolone acetate - 80mg/2ml	80mg/2ml	Injectable suspension	365,525 L.L
H02AB08	TRIACORT	G	Triamcinolone acetonide - 40mg/ml	40mg/ml	Injectable suspension	745,833 L.L
L02AE03	ZOLADEX LA	B	Goserelin (acetate) - 10.8mg	10.8mg	Injectable suspension	L.L
R07AA	INFASURF	B	Calfactant - 210mg/6ml	35mg/ml	Injectable suspension	40,596,749 L.L
R07AA	INFASURF	B	Calfactant - 105mg/3ml	35mg/ml	Injectable suspension	23,344,161 L.L
L01BC07	AZACITIDINE ARROW	G	Azacitidine - 25mg/ml	25mg/ml	Injectable suspension	10,967,854 L.L
L01BC07	LEUZADA	G	Azacitidine - 100mg	100mg	Injectable suspension	10,969,285 L.L